These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36873155)

  • 1. Design, synthesis, and cytotoxic evaluation of quinazoline derivatives bearing triazole-acetamides.
    Pedrood K; Taayoshi F; Moazzam A; Iraji A; Yavari A; Ansari S; Sajjadi-Jazi SM; Mohajeri-Tehrani MR; Garmsiri N; Haghpanah V; Soleymanibadi M; Larijani B; Hamedifar H; Adibpour N; Mahdavi M
    Heliyon; 2023 Feb; 9(2):e13528. PubMed ID: 36873155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation.
    Emami L; Hassani M; Mardaneh P; Zare F; Saeedi M; Emami M; Khabnadideh S; Sadeghian S
    BMC Chem; 2024 Jul; 18(1):125. PubMed ID: 38965630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
    El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
    Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Elwan A
    Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme.
    El-Adl K; El-Helby AA; Sakr H; Eissa IH; El-Hddad SSA; M I A Shoman F
    Bioorg Chem; 2020 Sep; 102():104059. PubMed ID: 32653608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
    Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
    Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annulated pyrazole derivatives as a novel class of urokinase (uPA) inhibitors: Green synthesis, anticancer activity, DNA-damage evaluation, and molecular modelling study.
    Farag PS; AboulMagd AM; Hemdan MM; Hassaballah AI
    Bioorg Chem; 2023 Jan; 130():106231. PubMed ID: 36335649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
    Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
    Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
    Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
    Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tetrazolopyrrolidine-1,2,3-triazole analogues as potent anticancer agents: design, synthesis and molecular docking studies.
    Gandham SK; Kudale AA; Allaka TR; Chepuri K; Jha A
    Mol Divers; 2024 Oct; 28(5):3313-3329. PubMed ID: 37938509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of 1,2,3-Triazole Tethered Thymol-1,3,4-Oxadiazole Derivatives as Anticancer and Antimicrobial Agents.
    Almalki ASA; Nazreen S; Malebari AM; Ali NM; Elhenawy AA; Alghamdi AAA; Ahmad A; Alfaifi SYM; Alsharif MA; Alam MM
    Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, anticancer activity and docking studies of novel quinazoline-based thiazole derivatives as EGFR kinase inhibitors.
    Raghu MS; Swarup HA; Shamala T; Prathibha BS; Kumar KY; Alharethy F; Prashanth MK; Jeon BH
    Heliyon; 2023 Sep; 9(9):e20300. PubMed ID: 37809937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2.
    Alkahtani HM; Abdalla AN; Obaidullah AJ; Alanazi MM; Almehizia AA; Alanazi MG; Ahmed AY; Alwassil OI; Darwish HW; Abdel-Aziz AA; El-Azab AS
    Bioorg Chem; 2020 Jan; 95():103461. PubMed ID: 31838290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR/Topo-1 inhibition.
    Halim PA; Sharkawi SMZ; Labib MB
    Bioorg Chem; 2023 Feb; 131():106273. PubMed ID: 36444790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA
    Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-proliferative activity of a novel 1,2,3-triazole tethered chalcone acetamide derivatives.
    Vanaparthi S; Bantu R; Jain N; Janardhan S; Nagarapu L
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127304. PubMed ID: 32631524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morpholine substituted quinazoline derivatives as anticancer agents against MCF-7, A549 and SHSY-5Y cancer cell lines and mechanistic studies.
    Dwivedi AR; Kumar V; Prashar V; Verma A; Kumar N; Parkash J; Kumar V
    RSC Med Chem; 2022 May; 13(5):599-609. PubMed ID: 35694693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of newly synthesized 1,1-disubstituted cyclohexane-1-carboxamides: in vitro caspases mediated apoptosis activators in human cancer cell lines and their molecular modeling.
    Abd-Allah WH; Salman A; Sabry Saad S
    Drug Dev Res; 2019 Nov; 80(7):933-947. PubMed ID: 31343754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents.
    Emami L; Sadeghian S; Mojaddami A; Khabnadideh S; Sakhteman A; Sadeghpour H; Faghih Z; Fereidoonnezhad M; Rezaei Z
    BMC Chem; 2022 Nov; 16(1):91. PubMed ID: 36369166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.